Transcriptomics

Dataset Information

0

A New Approach Methodology (NAM) Based Assessment of Butylated hydroxytoluene (BHT) for Endocrine Disruption (ED) Potential


ABSTRACT: We tested the hypothesis that BHT is an endocrine disruptor by using a Next Generation Risk Assessment (NGRA) method. Four different cell lines: A549, HCC1428, HepG2 and MCF7 were treated with BHT and a series of BHT analogs at 5 different concentrations, RNA was isolated from cell extracts and run on the L1000 gene array platform. A toxicogenomics-based assessment was performed by comparing BHT’s unique genomic signature to a large external database containing signatures of other compounds (including many known endocrine disruptors) to identify if any endocrine disruption-related modes of action (MoAs) are prevalent among BHT and other compounds with similar genomic signatures. In addition, we performed a toxicogenomics-based structure activity relationship (SAR) assessment of BHT and a series of structurally similar analogues to understand if endocrine disruption is a relevant MoA for chemicals that are considered suitable analogs to BHT using the P&G read across framework (Wu et al., 2010). The platform is GPL20573: Broad Institute Human L1000 epsilon http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GPL20573

ORGANISM(S): Homo sapiens

PROVIDER: GSE211553 | GEO | 2022/10/17

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-08-28 | GSE178201 | GEO
2017-03-03 | GSE92742 | GEO
2017-03-03 | GSE92743 | GEO
2015-07-15 | GSE70138 | GEO
2017-08-24 | GSE101406 | GEO
2014-05-27 | GSE57811 | GEO
2014-08-18 | GSE59895 | GEO
2014-05-27 | GSE57816 | GEO
2014-08-18 | GSE59926 | GEO
2014-08-18 | GSE59913 | GEO